Search
Dr. Ashok Seth

Dr. Ashok Seth

Chairman

45 Years of Experience

Interventional Cardiologist

MBBS, MRCP, FRCP, FACC, D.Sc

Reg. No.:6648, Delhi Medical Council

Fortis Escorts Heart Institute, Okhla, New Delhi

English

Consultation Fee ₹ 5000

Book an Appointment Contact with Doctor

Confirm Your Consultation With Dr. Ashok Seth

Expert Help When You Need It – Plan in 60 Minutes

About Dr. Ashok Seth

  • Dr. Ashok Seth is a highly esteemed Interventional Cardiologist with over 45 years of experience in the field of cardiovascular medicine.
  • His clinical expertise spans a wide range of procedures, including TAVR (Transcatheter Aortic Valve Replacement), cardiac ablation, cardiac catheterization, carotid angioplasty and stenting, coronary angiogram, coronary angioplasty/bypass surgery, computed tomography angiography (CTA), and mitral valve repair/replacement, among others.
  • Dr. Seth completed his MBBS from Jawaharlal Nehru Medical College, Aligarh, followed by an MD from SGPGI, Lucknow.
  • In recognition of his contributions to medicine, he has been awarded honorary doctorates from six prestigious institutions, including Aligarh Muslim University, Jamia Millia Islamia, Shiv Nadar University, Amity University, and Teerthankar Mahavir University.
  • He also holds Adjunct Professorships in Cardiology at J.N. Medical College, AMU, and the National Board of Examinations.
  • A pioneer in interventional cardiology, Dr. Seth is the founder and course director of five renowned national and international training programs: India Valves, India Live, CHIP-CTO India, AICT-Asia PCR, and the Imaging and Physiology Council of India.
  • He also serves as Associate Director of the TCT Scientific Sessions (USA) and is a Program Committee Member of Euro PCR.
  • Dr. Seth’s name appears in the Limca Book of Records for performing one of the highest numbers of angioplasties and angiographies worldwide.
  • He has played a pivotal role in the advancement of interventional cardiology across India and the Asia-Pacific region, introducing several innovative techniques and procedures.
  • Over the years, he has been a key speaker at more than 450 national and international conferences and has demonstrated complex angioplasty techniques live at over 100 global forums, including prestigious platforms like TCT (USA), Euro PCR (Paris), and Singapore Live.
  • Dr. Seth is also a prolific academician with over 350 peer-reviewed publications, contributions to 30 cardiology textbooks, and editorial leadership in three major cardiology books.
  • As an educator, he has mentored and trained over 500 cardiologists in India and abroad in advanced interventional techniques, making a lasting impact on the next generation of cardiovascular specialists.

Confirm Your Consultation With Dr. Ashok Seth

Expert Help When You Need It – Plan in 60 Minutes

Education

  • MBBS, Aligarh Muslim University, Aligarh, 1980
  • MRCP Royal Colleges Of Physicians and Surgeons, Ireland, 1986
  • Fellow of the Royal College of Physicians of Canada (FRCP), Canada, 1995 
  • Fellow of the American College of Cardiology (FACC), 1995
  • Doctor of Science (DSc.), Banaras Hindu University, 1998

OPD Schedule Of Dr. Ashok Seth

Book Appointment

Past Experience

  • Professor (Cardiology), Padmashree Dr. D Y Patil University, 2008
  • Chief (Interventional Cardiology), Max Heart and Vascular Institute, New Delhi, 2008
  • Chief (Interventional and Invasive Cardiology), Escorts Heart Institute New Delhi, 2004
  • Professor (Cardiology),  Gandhi Medical College, 2001
  • Consultant (Cardiology), Queen Elizabeth Hospital, Birmingham, 1988
  • IMA Distinguished Interventional Cardiologist Award
  • B C Roy Award in 2017
  • Padma Bhushan in 2015
  • Doc N Doc-Gammex Saviour Award in 2014
  • DMA Centenary Award in 2014
  • Hero Lifetime Achievement Award in 2014
  • Vishisht Chikitsa Ratan in 2012
  • Order of Isabella the Catholic in 2010
  • Mason Sones Award from the Society of Cardiovascular Angiography Interventions in 2010
  • Padma Shri in 2003Delhi Ratna Award in 2000
  • Safety and effectiveness of the novel Myval Octacor transcatheter heart valve in severe, symptomatic aortic valve stenosis — A real-world Indian experience (The OCTACOR India Study), 2024
  • Última generación de prótesis percutáneas expandibles con balón y autoexpandibles en la estenosis aórtica bicúspide: estudio TRITON, 2023
  • Angiographic quantification of aortic regurgitation following removal octacor implantation; independent core lab adjudication, 2023
  • One-Year Outcomes after Myval Implantation in Patients with Bicuspid Aortic Valve Stenosis-A Multicentre Real-World Experience, 2023
  • Transcatheter valve-in-valve or valve-in-ring implantation with a novel balloon-expandable device in patients with bioprosthetic left side heart valve failure: 1-year follow-up from a multicenter experience, 2023
  • Prosthetic valve thrombosis secondary to heparin-induced thrombocytopenia - Double trouble, 2022
  • Clinical expert consensus document on the use of percutaneous left ventricular assist devices during complex, high-risk PCI in India using a standardized algorithm, 2022
  • Transcatheter Aortic Valve Implantation for Severe Bicuspid Aortic Stenosis - 2 Years Follow-up Experience From India, 2022
  • Journal Pre-proof Impact of the 2017 ACC/AHA Guidelines on the Prevalence of Hypertension Among Indian Adults: Results from a Cross-Sectional Survey, 2020
  • Evaluation of Balloon Expandable Transcatheter Heart Valve in the Treatment of Severe Symptomatic Native Aortic Stenosis: The First-in-human MyVal-1 Study, 2020
  • First-in-Human Evaluation of Balloon Expandable Transcatheter Heart Valve in the Treatment of Severe Symptomatic Native Aortic Stenosis: The MyVal-1 Study, 2019
  • Prevalence of Hypertension among Indian Adults: Results from the Great India Blood Pressure Survey, 2019
  • Three-year clinical and two-year multimodality imaging outcomes of a thin-strut sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 trial, 2019
  • Chronic total occlusion or non? Chronic total occlusion percutaneous coronary intervention: Do myocytes care, 2019
  • TCT-64 Two-Year Clinical and Imaging Outcomes of Thin Strut Sirolimus-Eluting Bioresorbable Vascular Scaffolds in De Novo Coronary Artery Lesions: The MeRes-1 Trial, 2018
  • Long-term follow-up of BVS from a prospective multicenter registry: Impact of a dedicated implantation technique on clinical outcomes, 2018
  • TCTAP A-052 Long-term Outcomes and Technical Challenges of Treating Diffuse Coronary Artery Disease with Everolimus eluting Bioresorbable Vascular Scaffolds, 2018
  • 1968Quantitative angiographic analysis in patients with de novo native coronary artery lesions treated with novel poly-l-lactide based sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 Trial, 2017
  • First-in-human evaluation of a novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold for the treatment of de novo native coronary artery lesions: MeRes-1 trial, 2017
  • TCTAP A-003 First-in-human Evaluation of a Novel Poly-L-lactide Based Sirolimus-eluting Bioresorbable Vascular Scaffold for the Treatment of De Novo Native Coronary Artery Lesions: MeRes-1 Trial, 2017
  • TCTAP A-058 Favorable Outcomes for Systemic Pharmacokinetic Study of Sirolimus-eluting Bioresorbable Vascular Scaffold System in Treating De Novo Native Coronary Artery Lesion: A Sub Study of MeRes-1 Trial, 2017
  • CRT-700.04 Three-year Clinical Outcomes Of Biomime Sirolimus-eluting Coronary Stent System With A Biodegradable Polymer In Coronary Artery Disease Patients: A Long-term Follow-up Of The meriT-2 Study, 2017
  • CRT-700.01 Favourable Outcomes for Systemic Pharmacokinetic Study of Sirolimus-Eluting BioResorbable Vascular Scaffold System in Treating de novo Native Coronary Artery Lesion: A Sub Study of MeRes-1 Trial, 2017
  • TCT-434 Implantation of Absorb Bioresorbable Vascular Scaffolds in Small Vessel Coronary Artery Disease: Long-term follow-up, 2016
  • TCTAP A-004 Rotational Atherectomy and Stenting of Severely Calcified Coronary Arteries with Absorb Bioresorbable Vascular Scaffolds: Analysis of Outcomes, 2016
  • TCTAP A-054 Long-term Outcome Analysis of Stenting of Diffuse Coronary Lesions with Absorb Bioresorbable Vascular Scaffolds, 2016
  • Late angiographic and clinical outcomes of the novel BioMime™ sirolimus-eluting coronary stent with ultra-thin cobalt-chromium platform and biodegradable polymer for the treatment of diseased coronary vessels: results from the prospective, multicentre meriT-2 clinical trial, 2016
  • Late angiographic and clinical outcomes of the novel BioMime™ sirolimus-eluting coronary stent with ultra-thin cobalt-chromium platform and biodegradable polymer for the treatment of diseased coronary vessels: results from the prospective, multicentre meriT-2 clinical trial, 2016
  • Late angiographic and clinical outcomes of the novel BioMime™ sirolimus-eluting coronary stent with ultra-thin cobalt-chromium platform and biodegradable polymer for the treatment of diseased coronary vessels: results from the prospective, multicentre meriT-2 clinical trial, 2016
  • Late angiographic and clinical outcomes of the novel BioMime™ sirolimus-eluting coronary stent with ultra-thin cobalt-chromium platform and biodegradable polymer for the treatment of diseased coronary vessels: results from the prospective, multicentre meriT-2 clinical trial, 2015
  • Salvage of Side Branch by Provisional "TAP Technique" Using Absorb (TM) Bioresorbable Vascular Scaffolds for Bifurcation Lesions: First Case Reports with Technical Considerations, 2014
  • Use of 'Guidelines' catheter to overcome the failure of delivery of Absorb™ Bioresorbable Vascular Scaffold in calcified tortuous coronary lesions: Technical considerations in 'Real World Patients,' 2014
  • One-Year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis of the ABSORB and the SPIRIT Trials, 2014
  • TCT-212 Efficacy of the Novel BioMime Sirolimus-Eluting Stents with a Biodegradable Polymer in the Treatment of De Novo Coronary Lesions: An Angiographic Subanalysis of the Combined meriT-1 and meriT-2 Prospective Clinical Trials, 2013
  • TCT-36 One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSORB EXTEND Trials., 2013
  • The Paclitaxel-eluting PTCA-balloon in combination with a cobalt-chromium stent in two different sequences to treat de novo coronary artery lesions: An angiographic follow-up study, 2013
  • TCT-649 Safety and Efficacy of Overlapping Second Generation Drug-Eluting Stents Based Upon 2-year Clinical Outcomes. Results from the Pooled Analysis of Five Trials from the International Global RESOLUTE Program. Impact of the New BioMime™ Sirolimus-Eluting Stent in Complex Patients of Daily Practice – Preliminary Results of the MeriT-2 Study, 2012
  • TCT-649 Safety and Efficacy of Overlapping Second Generation Drug-Eluting Stents Based Upon 2-year Clinical Outcomes. Results from the Pooled Analysis of Five Trials from the International Global RESOLUTE Program. Impact of the New BioMime™ Sirolimus-Eluting Stent in Complex Patients of Daily Practice – Preliminary Results of the MeriT-2 Study, 2012
  • TCT-649 Safety and Efficacy of Overlapping Second Generation Drug-Eluting Stents Based Upon 2-year Clinical Outcomes. Results from the Pooled Analysis of Five Trials from the International Global RESOLUTE Program. Impact of the New BioMime™ Sirolimus-Eluting Stent in Complex Patients of Daily Practice – Preliminary Results of the MeriT-2 Study, 2012
  • Efficacy of Everolimus-Eluting Stent Implantation in Patients With Calcified Coronary Culprit Lesions: Two-Year Angiographic and Three-Year Clinical Results From the SPIRIT II Study, 2010
  • A pooled gender-based analysis comparing the XIENCE V (R) everolimus-eluting stent and the TAXUS paclitaxel-eluting stent in male and female patients with coronary artery disease, results of the SPIRIT II and SPIRIT III studies: two-year analysis, 2010
  • Mammary coronary artery anastomosis without cardiopulmonary bypass through mini-thoracotomy: one-year clinical experience 1 Presented at the 1st World Congress on Minimally Invasive Cardiac Surgery, Paris, May 30–31, 1997. 1, 1998
  • Percutaneous intra-aortic balloon pulsation for management of life-threatening emergencies in an intensive coronary care unit, 1993
  • Cardiological Society of India (CSI)

Best Cardiology Doctors in India

View All
View All
Enquiry Now